Top Markets
Coin of the day
Crescent Biopharma, Inc. Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
株式のランク #11764
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and... Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
株価
$17.81
最終同期: 2026-08-28
時価総額
$661.63M
変化(1日)
0.30%
変化(1年)
23.70%
US
取引 Crescent Biopharma, Inc. (CBIO)

カテゴリー

Crescent Biopharma, Inc.(CBIO)の配当利回りの履歴
Crescent Biopharma, Inc.(銘柄コード: CBIO)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Crescent Biopharma, Inc.(CBIO)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)